— Know what they know.
Not Investment Advice

PPLPHARMA.BO

Piramal Pharma Limited
1W: +1.4% 1M: -12.0% 3M: -27.9% YTD: -13.7% 1Y: -37.8% 3Y: +33.7%
₹143.35 ($1.52)
+2.25 (+1.59%)
 
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ₹186.7B · Alpha Radar Strong Sell · Power 26
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap₹186.7B ($2.0B)
52W Range134.7-241
Volume195,913
Avg Volume182,229
Beta0.00
Dividend₹0.14
Analyst Ratings
No analyst coverage
Company Info
CEOPeter Daniel DeYoung
Employees6,719
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2022-10-19
507, Skyline Wealth Space
Mumbai 400 086
IN
91 22 3802 3000
About Piramal Pharma Limited

Piramal Pharma Limited operates as a pharmaceutical company. It sells a portfolio of pharma products, as well as provides various pharma services, including injection, HPAPI, etc. The company was incorporated in 2020 and is based in Mumbai, India. Piramal Pharma Limited operates as a subsidiary of Piramal Enterprises Limited.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms